• No results found

Plasmacytoid dendritic cells: how to control the good, the bad, and the ugly at the molecular level - Title pages

N/A
N/A
Protected

Academic year: 2021

Share "Plasmacytoid dendritic cells: how to control the good, the bad, and the ugly at the molecular level - Title pages"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Plasmacytoid dendritic cells: how to control the good, the bad, and the ugly at

the molecular level

Karrich, J.J.

Publication date

2013

Link to publication

Citation for published version (APA):

Karrich, J. J. (2013). Plasmacytoid dendritic cells: how to control the good, the bad, and the

ugly at the molecular level.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

(2)

Claire once asked me what is it that I do at work exactly?

This was my answer, lets imagine a picture/slide of

a living immune cell including all the detailed molecular

processes (a lot of them) occurring in the cell in order

to keep it alive and then this picture is covered with millions

of playing cards so it is completely hidden like so you are

playing the MEMORY game. Well my job is to try and figure out

using various molecular biology techniques to be able

to turn over one or a few cards to see what it is hiding

and then publish what I discover in peer reviewed scientific

journals. However the major problem is I don’t believe that

anybody will ever be able to discover what all the cards are

hiding so that we can see the entire picture.

(3)
(4)

Plasmacytoid dendritic cells:

how to control the good, the bad,

and the ugly at the molecular level

(5)

ISBN: 978-94-6182-231-4

Printing of this thesis was supported by the Academic Medisch Centrum, University of Amsterdam, Amsterdam, The Netherlands.

Background cover:

http://4.bp.blogspot.com/- CcmJnc_NlFw/UFCo5OZL2xI/AAAAAAAABTM/ hqyIlMKSI6Q/s1600/western-hills-andsky-wall-inkbluesky.png

Back cover pictures, from top to bottom.

The good: Freshly isolated human plasmacytoid dendritic cells from blood. Magnification 20x (Leica).

The bad: Overnight activated human plasmacytoid dendritic cells with the TLR9 agonist CpG-B (10μg/mL). Magnification 20x (Leica).

The ugly: Leukemic plasmacytoid dendritic cell line CAL-1 isolated from a patient with CD4+CD56+ hematodermic neoplasm [Maeda et al., Int J Hematol. 2005;81(2):148-154.]. Magnification 20x (Leica).

Lay-out and printing: Off Page, www.offpage.nl

Copyright © 2012 by J.J. Karrich. All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, without prior permission of the author.

(6)

Plasmacytoid dendritic cells:

how to control the good, the bad,

and the ugly at the molecular level

ACADEMISCH PROEFSCHRIFT

ter verkrijging van de graad van doctor

aan de Universiteit van Amsterdam

op gezag van de Rector Magnificus

prof. dr. D.C. van den Boom

ten overstaan van een door het college voor promoties

ingestelde commissie,

in het openbaar te verdedigen in de Agnietenkapel

op dinsdag 19 februari 2013, te 10:00 uur

door

Julien Jamal KARRICH

geboren te Reims, Frankrijk

(7)

Promotiecommissie

Promotor

prof. dr. H. Spits

CCo-promotor

dr. B. Blom

Overige Leden

prof. dr. J. de Vries

prof. dr. S.M. van Ham

prof. dr. T.B.H. Geijtenbeek

prof. dr. M.L. Kapsenberg

prof. dr. E.F. Eldering

dr. V. Soumelis

Faculteit der Geneeskunde

Referenties

GERELATEERDE DOCUMENTEN

In this study, we determined effects of miRNA inhibition on cHL cell growth using a high-throughput screen with a pool of miRNA inhibition constructs and a

Healthh workers in the field lack tools which could assist in establishing an early diagnosis, monitoringg chemotherapy and the emergence of relapse, and identifying patients with a

The interpretation of the dipstick results as positive or negative wass unequivocal, as illustrated by the high agreement between different persons reading thee test (Kappa

Together,, these results confirm the good concordance between dipstick assay and ELISA resultss using sera, reported previously and in addition, show that the agreement is equally

Here, we have explored thee possibility of using the detection of antibodies to PGL-I through a simple dipstick assayy as a marker for the bacterial load of a patient and

Here, we have explored the possibility of usingg the detection of antibodies to PGL-I through a simple dipstick assay as a marker for thee bacterial load of a patient and thus for

Leprosyy control programs would highly benefit from an easy method to estimate the prevalencee of disease and to assess the effect of leprosy control measures on the prevalencee

From this it can be concluded that dipstick positivity is a risk factorr for the future development of relapses, especially in those groups of patients who receivee